Suicide-Gene Transfection of Tumor-tropic Placental Stem Cells employing Ultrasound-Responsive Nanoparticles

Autor: Paris, Juan L., de la Torre, Paz, Cabanas, M. Victoria, Manzano, Miguel, Flores, Ana I., Vallet-Regi, Maria

Publikováno v: Acta Biomaterialia. 83, 372-378 (2018)

A Trojan-horse strategy for cancer therapy employing tumor-tropic mesenchymal stem cells transfected with a non-viral nanovector is here presented. In this sense, ultrasound-responsive mesoporous silica nanoparticles were coated with a polycation (us

Externí odkaz: http://arxiv.org/abs/2103.08984

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Premature senescence of placental decidua cells as a possible cause of miscarriage produced by mycophenolic acid.

Autor: de la Torre, Paz¹ (AUTHOR), Fernández-de la Torre, Miguel² (AUTHOR), Flores, Ana I.¹ (AUTHOR) anaisabel.flores@salud.madrid.org

Publikováno v: Journal of Biomedical Science. 1/4/2021, Vol. 28 Issue 1, p1-14. 14p.

New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies

Autor: Paris, Juan L., de la Torre, Paz, Flores, Ana I.

Allergy constitutes a major health issue due to its large prevalence. The established therapeutic approaches (allergen avoidance, antihistamines, and corticosteroids) do not address the underlying causes of the pathology, highlighting the need for ot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2636::2ac5f27554134235230aa5e1f77fcdbe
https://hdl.handle.net/10668/4125

Endostatin genetically engineered placental mesenchymal stromal cells carrying mesoporous silica nanoparticles for combined chemo- and antiangiogenic therapy

Autor: De la Torre, Paz, Paris, J. L., Fernández de la Torre, Miguel, Vallet Regí, María, Flores, Ana I.

Publikováno v: E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
E-Prints Complutense. Archivo Institucional de la UCM
instname

Combination therapies constitute a powerful tool for cancer treatment. By combining drugs with different mechanisms of action, the limitations of each individual agent can be overcome, while increasing therapeutic benefit. Here, we propose employing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::345061abe3d2a9f24a1cd6a8ea26a221
https://eprints.ucm.es/id/eprint/63975/